Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

TUMOR IMMUNOLOGY

CD36 — the Achilles’ heel of Treg cells

Nature Immunology volume 21, pages 251–253 (2020)Cite this article

Subjects

Regulatory T (Treg) cells suppress antitumor immunity, but Treg cell inhibition has been hampered by a lack of specific targets. CD36 expression by tumor-infiltrating Treg cells may provide a way to specifically target Treg cells in tumors.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Treg cells suppress effector T cells in the tumor microenvironment and in healthy tissues.

References

  1. Horton, B. L. et al. Cancer Immunol. Res. 6, 14–24 (2018).

    Article  CAS  Google Scholar 

  2. Wang, H. et al. Nat. Immunol. https://doi.org/10.1038/s41590-019-0589-5 (2020).

  3. Jansen, C. S. et al. Nature 576, 465–470 (2019).

    Article  CAS  Google Scholar 

  4. Spranger, S. et al. Sci. Transl. Med. 5, 200ra116 (2013).

    Article  Google Scholar 

  5. Bos, P. D. et al. J. Exp. Med. 210, 2435–2466 (2013).

    Article  Google Scholar 

  6. Sakaguchi, S. et al. J. Immunol. 155, 1151–1164 (1995).

    CAS  PubMed  Google Scholar 

  7. Simpson, T. R. et al. J. Exp. Med. 210, 1695–1710 (2013).

    Article  CAS  Google Scholar 

  8. Sharma, A. et al. Clin. Cancer Res. 25, 1233–1238 (2019).

    Article  Google Scholar 

  9. Kim, J. M., Rasmussen, J. P. & Rudensky, A. Y. Nat. Immunol. 8, 191–197 (2007).

    Article  CAS  Google Scholar 

  10. Wildin, R. S. et al. Nat. Genet. 27, 18–20 (2001).

    Article  CAS  Google Scholar 

  11. Maj, T. et al. Nat. Immunol. 18, 1332–1341 (2017).

    Article  CAS  Google Scholar 

  12. Field, C. S. et al. Cell Metab. https://doi.org/10.1016/j.cmet.2019.11.021 (2019).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Koch Institute for Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, MA, USA

    Brendan L. Horton & Stefani Spranger

  2. Biology Department, Massachusetts Institute of Technology, Cambridge, MA, USA

    Stefani Spranger

  3. Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA

    Stefani Spranger

Authors
  1. Brendan L. Horton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefani Spranger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefani Spranger.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Horton, B.L., Spranger, S. CD36 — the Achilles’ heel of Treg cells. Nat Immunol 21, 251–253 (2020). https://doi.org/10.1038/s41590-020-0601-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-020-0601-0

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer